Table 1. Summary of review of the literature on GCTs of the carpal bones.

No.	Authors	Year	Age	Sex	Bone(s)	Duration	Treatment	Outcome
1	Abdu et al 10	1994	30	M	Scaphoid	6 mo	Resection and silicone implant	Mild reactive silicone synovitis Good wrist function and no evidence of recurrent disease
2	Gupta et al 5	1995	30	M	Capitate, hamate, and triquetrum		Distal row carpectomy with reconstruction of the left wrist with a bicortical iliac autogenous bone graft and arthrodesis of the distal carpal segment to metacarpals	No recurrence with good hand function on 18-mo follow-up
3	Kew et al 11	2000	18	M	Scaphoid	2 mo	Resection and a pronator quadratus pedicle bone grafting with radioscaphoid fusion	No recurrence was found on 7-y follow-up
4	Sakayama et al 12	2008	24	F	Hamate	3 mo	Curettage with acrylic cementation	No recurrence with 100% functional recovery on 3-y follow-up
5	Tarng et al 13	2009	29	F	Scaphoid, capitate, trapezium, and trapezoid		En bloc resection through a dorsal and volar approach for soft tissue resection, with defect filled autologous with bicortical iliac crest bone graft	No evidence of clinical and radiological evidence of recurrence on 1-y follow-up
6	Kotnis et al 14	2009	44	M	Triquetrum	8 mo	Surgical exploration and local curettage	The patient was symptom-free till for 4 m
7	Angelini et al 15	2011	21	F	Capitate	7 mo	Curettage + phenol ablation + morselized corticocancellous bone allograft	Recurrence noticed after 5 mo
8	Oufkir et al 16	2017	48	F	Capitate	1 y	Staged procedure  Curettage and bone cement  Corticocancellous bone graft from the iliac crest, with lunometacarpal arthrodesis	Complex regional pain syndrome in the early postoperative period 2 y after surgery: pain-free with functional range of motion (30 degrees of extension, 25 degrees of flexion), the grip strength was 50% of that of the unaffected side
9	Afsharet al 17	2018	16	F	Capitate	6 mo	Intralesional curettage + alcohol ablation + allogenic bone graft	Satisfactory hand function without any recurrence at 2-y follow-up

Abbreviations: F, female; GCT, giant cell tumor; M, male.